Using an mRNA versus DNA test in the English cervical screening programme can save £15m annually and reduce unnecessary testing
The results of our economic evaluation comparing the use of mRNA and DNA assays in screening for cervical cancer in England were published in BMJ Open and are now available online. Results show large cost savings from avoiding unnecessary testing and follow-up, which can benefit women and healthcare services. Read More >
Aquarius welcomes new team members
We’re delighted to welcome Shona and Ben to the Aquarius team. Read More >
Aquarius welcomes new team members
We’re pleased to have welcomed two new members of the Aquarius team since moving to our new office in Tileyard back in 2018. Read More >
Supporting access to clean drinking water in Africa
At Aquarius Population Health we understand the importance of keeping our team well hydrated to support their health and top performance throughout the day. As a result, we decided to invest in a water-cooler and water-heater from AquAid. Read More >
Could a same day test and treatment service in further education colleges improve uptake of chlamydia testing among young people?
Aquarius were part of a recent feasibility trial looking at whether provision of a same day test and treatment service for chlamydia in further education colleges increased uptake of chlamydia testing and treatment. The results of the trial were published this week in Clinical Microbiology and Infection and are available online. Read More >
Evaluating multi-bug point-of-care tests for diagnosing STIs
New point-of-care (POC) tests are currently being developed which can be used in clinic to simultaneously test for multiple sexually transmitted infections (STIs). In work now published online in BMJ Open, we developed a model to compare three possible strategies for POC STI testing with the current practice of microscopy and lab-based testing. The three Read More >
The NHS wastes more than £7 billion because it’s slow to use new diagnostics
An article authored by Aquarius was published today on the British In Vitro Diagnostics Association (BIVDA) website. The article commissioned jointly by BIVDA and Innovate UK suggests that the NHS could save over £6.9 billion in 5 years by making better use of diagnostic tests already on the market. These savings could have a huge Read More >
Aquarius go wild! An outdoor learning adventure
At Aquarius, we love an opportunity to learn new skills and work together as a team to produce something we’re proud of. Our team away day was no exception. In an 800-acre forest in the depths of West Sussex, we spent the day in our outdoor gear learning some bush craft and how we can Read More >
Assessing the impact of point-of-care testing for influenza and RSV in children admitted to hospital
The winter flu season brings added pressure to emergency and acute hospital services. In the UK, children and infants account for more than a third of flu related hospital admissions since flu and respiratory syncytial viruses (RSV) can be particularly severe in children, particularly those with existing conditions such as asthma. In our recent paper Read More >
Exploring In-Vitro Diagnostics and Medical Devices at the European MedTech Forum
In January, Elisabeth, Mike and I attended the European MedTech Forum in Brussels, a three-day annual event which brings together key players from the world of in-vitro diagnostics and medical devices. We enjoyed engaging with senior decision-makers from across Europe and beyond, including representatives from small start-ups to large multinationals. Read More >